CS250889B1 - Chlorotetracycline-producing Streptomyces aureofaciens CCM 3820 strain and resistant to phage infection - Google Patents
Chlorotetracycline-producing Streptomyces aureofaciens CCM 3820 strain and resistant to phage infection Download PDFInfo
- Publication number
- CS250889B1 CS250889B1 CS458085A CS458085A CS250889B1 CS 250889 B1 CS250889 B1 CS 250889B1 CS 458085 A CS458085 A CS 458085A CS 458085 A CS458085 A CS 458085A CS 250889 B1 CS250889 B1 CS 250889B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- strain
- chlorotetracycline
- ccm
- resistant
- phage infection
- Prior art date
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Riešenie sa týká kmeňa mikroorganizmu Streptomyces auiretífaiciems CCM 3820 produikujúceho chíórtetracyklin a odolného voči fáigovej infekci.The solution relates to a strain of the microorganism Streptomyces auritifiaciems CCM 3820 producing chlorotetracycline and resistant to phage infection.
Description
.? 5 O 8 8 9 3 4.? 5 O 8 8 9 3 4
Vynález ,sa týká kmetí a Streptomycesaureofaciens CGM 3820 (interně označeniekmeňa je UV 712/84-31) produlkujúceho chlór-tetracyklíu, vyznačujúcého sa odolnosťouvoči fágovej Infekcii a stabilitou vlastnostív následujúcich generáciách.The invention relates to the progenitor and Streptomycesaureofaciens CGM 3820 (internally designation is UV 712 / 84-31) prodrug chlorotetracycline, characterized by resistance to phage infection and stability of the properties of subsequent generations.
Zvýšenie priemyselnej výroby antibiotikachlórtetracyklínu je najčastejšie založenéna vyššej produkčnej schopnosti kmeňov po-užívaných na fotosyntézu. Tieto 'kmene musiavykazovat specifické vlastnosti, ktoré saprejavujú pri fermentácii vo výrobnom za-riadení. Ido najma o udržanie vysekej pro-dukčně] schopnosti a odolnosti voči ne-priaznivým vplyvom v priefoehu fermentá-cie, z ktorých najvačšie nefoezpečenstvopředstavuje fágová infekcia.Increasing the industrial production of antibiotic chlorotetracycline is most often based on higher production ability of photosynthetic strains. These strains need to exhibit specific properties that they exhibit in fermentation in the plant. In particular, it maintains the high production ability and resistance to adverse effects in the fermentation phase, of which phage infection is the most dangerous.
Kmen Streptomyces aureofaciens CCM3820 hol získaný radům za sebou natsledu-júcich mutagénnych zásahov a pasivnýchselekcií z kmeňa Streptomyces aureofaciensCCM 3766.Streptomyces aureofaciens strain CCM3820 hol obtained by a series of consecutive mutagenic interventions and passive selections from Streptomyces aureofaciensCCM 3766.
Dalšími Ikmeňmii v genealogie,kej linii holiCCM 3767 a kmeň s interuým označenímUV 71/84-15. Na tento' kmeň bol vedený po-isleidný zásah UV světlo,m 'dávkou 214 J.m~zs nasledujúoou selekctou v kvapalnom apevnoin médiu obsáhujúcom vlastný meta-foolit — chlórtetracyklín s koncentráciou170 a 670 ,wig v mililitri média. Získané vy-sporulované kolonie holi preočkovatné našikmé aigary .so štandardnou sporulačnoupůdou. Vysporulované kultúry holi uložené pri teplotě +4 °C na dobu 20 týždňov. Zauvedených podmienok zachovala si rastovévlastnosti jedna třetina Ikultúr. Tieto, kultú-ry holi testované na produkonú aktivitu po-dlá systému spory---< vegetativně inokulum---> ---- fermentácia a z nich bol získaný kmeň Streptomycesaureofaciens CCM 3820, .na ktorý je uplat-ňovaný patentový nárok. ·Other Ikmeňmii in genealogy, holiCCM line 3767 and tribe designationUV 71 / 84-15. UV light, a 214 µm dose, followed by selection in liquid apevnoin medium containing intrinsic meta-foolite-chlorotetracycline at a concentration of 170 and 670 µg in milliliter medium was conducted on this strain. The obtained sporulated colonies of the booster vaccinated sigars with standard sporulation. The spore cultures were stored at + 4 ° C for 20 weeks. One-third of the cultures retained the above-mentioned conditions. These cultures tested for production activity according to the spore system by fermentation and obtained from the strain Streptomycesaureofaciens CCM 3820, which is claimed. ·
Kmeň je charakteristický získanými, preaktinofág B1 nepriaznivými hostitelskýmivlastnosťami a vysokou produkciou antibio-tika, ktorú dosahuje za určených podmienokkultivácie. Tvar kolonií, vyrastených na spo-rulačnej ,póíde po monospórovom rozseve,ich pigmentácia ako aj farba spor sú rov-naké ako u východzieho kmeňa. CCM 3766.Rast kmeňa CCM 3820 je na pevných i kva-palných půdách pomatší ako u východziehokmeňa.The strain is characterized by the obtained, preactinophage B1 unfavorable host properties and high antibiotic production which reaches under specified conditions of cultivation. The shape of the colonies grown on the spoil, the monospore sowing, their pigmentation and the color of the spores are the same as those of the initial strain. CCM 3766.Rast strain CCM 3820 is slower on both solid and liquid soils than on the ground.
Mikroskopické preparáty kultúry z fer-unentácie kmeňa CCM 3820 sú charakteris-tické tenkými, krátkými a bohato větvenýmivláiknamí. Sporuláeia kmeňa CM 382,0 a ,kul-tivácia jeho vegetatívnej formy vyžadujúdodržovanie určených podmienok kultivá-cie. V nasledujúcej tabutke je uvedené po-rovnaní,e vlastností kmeňa s vlastnosťamiprodukčných kmeňov CCM 3766 a CCM 3767.Microscopic preparations of culture from ferentation of strain CCM 3820 are characterized by thin, short and rich branched strands. The spores of strain CM 382.0 a, cultivation of its vegetative form, require observance of the specified culture conditions. The following table shows a comparison of the strain characteristics with the CCM 3766 and CCM 3767 production strains.
Kmeň Produkci,a chlórtetracyklínu v foanke Důkaz fága v kultúre ((Ug. ml-1) (%) (°/o z počtu kultúr) CCM 3766 4 900 100 '79 CCM 3767 5 200 106 50 CCM 3820 (UV 72/84-31) 5 400 110 menej alko 2 Příklad 1Strain Production, and chlortetracycline in foank Evidence of phage in culture ((Ug. Ml-1) (%) (° / oz number of cultures) CCM 3766 4 900 100 '79 CCM 3767 5 200 106 50 CCM 3820 (UV 72 / 84- 31) 5,400,110 less alcohol 2 Example 1
Podlá doterajšieho spůsobu kultivácieprodukčnéh©, kmeňa vegetativně inokulumpřipravuje sa v 500 ml varnej foanke so 60mililitrovej inokulačnej živnej půdy, ktoráobsahuje základné živiny, a to sacharózuako zdroj uhlíka, kukuřičný výluh, sójovúmúku a amónnu sol' ako zdroje dusíka auhličitan vápenatý. Půda na přípravu vege-tatívneho inokula očkuje sa sporami z jed-nej třetiny kultúry na šikmom agare a ne-chá inkufoovať 22 hodin.According to the prior art cultivation process, the strain is vegetatively inoculated in a 500 ml boiling pot with a 60 ml inoculum broth containing basic nutrients, namely sucrose as a source of carbon, corn liquor, soybean and ammonium salt as the nitrogen source of calcium carbonate. The soil for the preparation of the inoculum is inoculated with spores from one-third of the culture on slanted agar and not incubated for 22 hours.
Vegetatívnym inokulom očkuje sa 500 mlvarná banka so so 60 ml produkčnej živnejpůdy. Zdrojem uhlíka v tejto pode je sacha-róza, zdrojmi dusíka sú kukuřičný výluh,sójová múka a amónna sol'. Půda ďalej ob-sahuje uhličitan vápenatý, foenzylttokyanáta minerálně soli. Příprava ivegetaiívneho inokula a fermen-tácia prefoiehajú na rotačnom trepacom 'Stro-ji pri 240 .ot./min-1, výstřednosti 2,5 cm akultivačnej teplotě 29 °C. Fermentácia trvá 4 dni. Vzorky na stanovenie produkcie an-tibiotika oidoberajú sa v 96. hodině, kedy sadosahuje najvyššia produikcia. Vyššie uve-deným postupem dosahujú sa produkciechlórtetracyklínu 4 700 až 5 200 ,ug . ml-1půdy. P r í k 1 a d 2The vegetative inoculum is seeded with a 500 ml flask with 60 ml of production broth. The source of carbon in this substrate is sucrose, the sources of nitrogen are corn liquor, soy flour and ammonium salt. The soil further comprises calcium carbonate, foenzyltethanate mineral salts. The preparation of the ivegetic inoculum and the fermentation are run on a rotary shaker at 240 rpm for an eccentricity of 2.5 cm at a cultivation temperature of 29 ° C. The fermentation lasts for 4 days. Samples for the determination of antibiotic production are taken at the 96th hour when the highest production rate is reached. By the above process, the production of chlorotetracycline is 4,700-5,200 µg. ml-1 soil. Example 1
Podlá doterajšieho spůsobu kultivácie tpro-dukčného kmeňa v příklade 1 ,s tým rozdie-lom, že příprava vegetatívneho inokula afermentácia prébiehajú vo vellkoofojemovejaparatúre. Inokulum připravuje sa v ino-'kulačnom tanku s objemem 5 m3, ktorý jenaplněný 3 m,3 živnej půdy. Vegetatívnyminokulom očkuje sa produkčná živná půdavo fermentore s ofojemom 50 m3, ktorý jeplněný 29 ,m3 živnej půdy. Benzylttokyanátiprítokuje sa v množstve 1 až 1,5 (ug. ml-1půdy spolu s prikrm,ovacím roztokom, kte-rého přítok,ovanie začína pri spotřebovanízdroja uhlíka na hladinu 26 až 25 mg. ml-1According to the prior art cultivation of theproduct strain in Example 1, except that the preparation of the vegetative inoculum and fermentation proceeds in a large-scale camera. The inoculum is prepared in an inoculum tank with a volume of 5 m 3, which is filled with 3 m 3 of broth. The vegetative seed is seeded with a production nutrient fermenter of 50 m3, filled with 29 m3 of nutrient broth. Benzyltethanate is fed at 1 to 1.5 (µg / ml) together with a feed solution, where the feed starts when the carbon source is consumed to a level of 26 to 25 mg.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS458085A CS250889B1 (en) | 1985-06-21 | 1985-06-21 | Chlorotetracycline-producing Streptomyces aureofaciens CCM 3820 strain and resistant to phage infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS458085A CS250889B1 (en) | 1985-06-21 | 1985-06-21 | Chlorotetracycline-producing Streptomyces aureofaciens CCM 3820 strain and resistant to phage infection |
Publications (1)
Publication Number | Publication Date |
---|---|
CS250889B1 true CS250889B1 (en) | 1987-05-14 |
Family
ID=5388901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS458085A CS250889B1 (en) | 1985-06-21 | 1985-06-21 | Chlorotetracycline-producing Streptomyces aureofaciens CCM 3820 strain and resistant to phage infection |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS250889B1 (en) |
-
1985
- 1985-06-21 CS CS458085A patent/CS250889B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI90091B (en) | FOERFARANDE FOER PRODUCERING AV ICKE-NATURLIGA DEMETYLAVERMEKTINER | |
KR20010023454A (en) | Rice blast control agent and wheat scab control agent | |
KR960013432B1 (en) | Antimicrobial agent fr 109615 and production thereof | |
OMURA et al. | Luminamicin, a new antibiotic production, isolation and physico-chemical and biological properties | |
CS276983B6 (en) | Process for preparing a-21978c antibiotic in the form of a complex or its factors | |
CA1225053A (en) | Methods and compounds and compositions for treating protozoal infections with a novel antibiotic | |
US4123612A (en) | 7-(5-Amino-5-carboxyvaleramido)-3-(carbamoyoloxymethyl)-3-cephem-4-carboxylic acid | |
US4954641A (en) | Novel antitumor antibiotic substance and a method for production thereof | |
CS250889B1 (en) | Chlorotetracycline-producing Streptomyces aureofaciens CCM 3820 strain and resistant to phage infection | |
US4173702A (en) | 7-(5-Amino-5-carboxyvaler-amido)-3-(carbamoyloxymethyl)-7-methoxy-3-cephem-4-carboxylic acid | |
US5126350A (en) | Polycyclic aromatic antifungal compounds | |
RU95107036A (en) | Method of production of microbiological preparations | |
US3619374A (en) | Antibiotic production utilizing streptomyces refuineus var. thermotolerans | |
CA2811635A1 (en) | Improved procedure for the production of tiacumicin b | |
US4681846A (en) | Process for the preparation of difficidin and derivative antibacterials | |
CA1292713C (en) | Process for producing antibiotic salinomycin | |
US4600691A (en) | R-(Z)-4-amino-3-chloro-2-pentenedioic acid, novel antibacterial agent | |
US4845037A (en) | Process for producing antibiotic LL-D42067α | |
SU1316239A1 (en) | Method of producing proteolytic enzymes | |
EP0436935A1 (en) | A novel antibiotic Alisamycin a process for its production and its use | |
EP0137498B1 (en) | R-(z)-4-amino-3-chloro-2-pentenedioic acid, novel antibacterial agent | |
RU2098483C1 (en) | Method of avermectin preparing, strain streptomyces avermitilis - a producer of avermectin | |
RU2110577C1 (en) | Strain of streptomyces cremeus 1979 - a producer of apramycin | |
SU1423550A1 (en) | Strain of frankia sp actinomycete for producing compound stimulating growth of sea buckthorn | |
KR960009723B1 (en) | New microorganism of streptomyces genus, and new antibiotic from it and processing method of new antibiotic |